IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 115 filers reported holding IMMUNOVANT INC in Q1 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $621 | -99.9% | 32,736 | -65.6% | 0.06% | -11.4% |
Q3 2022 | $531,000 | +242.6% | 95,146 | +139.0% | 0.07% | +204.3% |
Q2 2022 | $155,000 | -55.2% | 39,817 | -2.1% | 0.02% | -46.5% |
Q4 2021 | $346,000 | -50.9% | 40,654 | -49.9% | 0.04% | -40.3% |
Q3 2021 | $705,000 | +195.0% | 81,170 | +1468.5% | 0.07% | +84.6% |
Q4 2020 | $239,000 | – | 5,175 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Alpine Global Management, LLC | 4,448,017 | $17,347,000 | 4.39% |
Deep Track Capital, LP | 9,455,000 | $36,875,000 | 2.42% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233 | $60,000,000 | 0.63% |
Octagon Capital Advisors LP | 579,061 | $2,258,000 | 0.60% |
Eventide Asset Management | 5,372,512 | $20,953,000 | 0.45% |
WITTENBERG INVESTMENT MANAGEMENT, INC. | 174,000 | $679,000 | 0.29% |
Frazier Life Sciences Management, L.P. | 585,759 | $2,284,000 | 0.22% |
BCK CAPITAL MANAGEMENT LP | 54,293 | $212,000 | 0.16% |
PLATINUM INVESTMENT MANAGEMENT LTD | 777,590 | $3,033,000 | 0.12% |
Bridgefront Capital, LLC | 15,649 | $61,000 | 0.07% |